News

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...
WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...
By Sharon AtienoWith traditional, complementary and integrative medicine (TCIM) being practiced in 170 countries and used by ...
LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...
More than 14 million children around the world have not received a single dose of any vaccine, according to new data from the World Health Organization and UNICEF.
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
In 2024, 89% of infants globally – about 115 million – received at least one dose of the diphtheria, tetanus and pertussis ...
Two litres of tap water in the regional New South Wales town of Walgett has as much sodium as an entire large bag of sea salt ...
World Health Organization (WHO) recommends injectable lenacapavir for Human Immunodeficiency Virus (HIV) prevention ...
As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...
The World Health Organization, alongside the International Telecommunication Union and the World Intellectual Property Organization, has released a technical report warning of risks associated with ...
The World Health Organization (WHO) is recommending a twice-yearly injection of lenacapavir for prevention of HIV, according ...